Christine Tran

Dr. Christine Tran

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KZKena Zhang
Kena Zhang
CTChristine Tran
Christine Tran
MAMouad Alami
Mouad Alami
Abdallah HamzeAbdallah Hamze
Abdallah Hamze
OPOlivier Provot
Olivier Provot
This review concerns the synthesis and biological activities of pyrazino[1,2-a]indoles and pyrazino[1,2-a]indol-1-ones reported since 1997 and the discovery of biological activity of pyrazinoindole derivatives. In the first part, we first presented the synthetic routes that have been reported from a methodological point of view to access the pyrazinoindole unit according to cyclization reactions using or not using metal catalysts. Then, syntheses and neuropsychiatric, auto-immune, anti-infectious and anti-cancer properties of pyrazinoindoles were detailed. In the second part, we first reported the main accesses to pyrazinoindol-1-one substrates according to Michael reactions, metal-catalyzed and metal-free cyclization reactions. The syntheses and anti-cancer, anti-infectious, anti-allergenic and neuropsychiatric properties of pyrazinoindolones were next described and discussed.

27 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
CTChristine Tran
Christine Tran
Abdallah HamzeAbdallah Hamze
Abdallah Hamze
Imidazopyridines constitute one of the most important scaffolds in medicinal chemistry, as their skeleton could be found in a myriad of biologically active molecules. Although numerous strategies were elaborated for imidazopyridine preparation in the 2010s, novel eco-compatible synthetic approaches have emerged, conscious of climate change concerns. In this framework, photochemical methods have been promoted to conceive this heterocyclic motif over the last decade. This review covers the recently published works on synthesizing highly functionalized imidazopyridines by light induction.

18 August 2022 in Chinese Chemical Letters
Verified
Journal Article
Closed access
CTChristine Tran
Christine Tran
AAAïcha Abdallah
Aïcha Abdallah
VDValentin Duchemann
Valentin Duchemann
GLGuillaume Lefèvre
Guillaume Lefèvre
Abdallah HamzeAbdallah Hamze
Abdallah Hamze

27 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CTChristine Tran
Christine Tran
Abdallah HamzeAbdallah Hamze
Abdallah Hamze
Histone deacetylases (HDACs) have become one of the main targets in cancer therapy due to their involvement in various biological processes, including gene regulation, cell proliferation, and differentiation. Microtubules, as key elements of the cell cytoskeleton, also represent important therapeutic targets in anticancer drugs research. These proteins are involved in diverse cellular functions, especially mitosis, cell signaling, and intracellular trafficking. With the emergence of multi-target therapy during the last decades, the combination of HDAC and tubulin inhibitors has been envisioned as a practical approach for optimizing the therapeutic efficacy of antitumor molecules. HDAC/tubulin dual-targeting inhibitors offer the advantages of the synergistic action of both compounds, along with a significant decrease in their respective toxicities and drug resistance. This review will detail the major recent advancements in the development of HDAC/tubulin dual inhibitors over the last decade and their impact on anticancer drugs discovery.

11 January 2022 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
KZKena Zhang
Kena Zhang
OPOlivier Provot
Olivier Provot
MAMouad Alami
Mouad Alami
CTChristine Tran
Christine Tran
Abdallah HamzeAbdallah Hamze
Abdallah Hamze

16 June 2023 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
JYJun Yan
Jun Yan
CTChristine Tran
Christine Tran
PRPascal Retailleau
Pascal Retailleau
MAMouad Alami
Mouad Alami
Abdallah HamzeAbdallah Hamze
Abdallah Hamze